MARK KESSEL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

DYNAVAX TECHNOLOGIES CORP

Filing Date Source Excerpt
2012-04-25 Mark Kessel 70 Director ... The following table shows for the fiscal year ended December 31, 2011 certain information with respect to the compensation of all non-employee directors of the Company: Mark Kessel $38,500 $22,846 $61,346
2013-04-29 Mark Kessel 71 Director ... The following table shows for the fiscal year ended December 31, 2012, certain information with respect to the compensation of all non-employee directors of the Company: Mark Kessel Fees Earned or Paid in Cash $45,500 Options and Awards Granted $183,419 Total $228,919 ... Mr. Kessel has chosen not to stand for election for another term.

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2008-10-30 The Company has given Holdings the right to appoint two members to its Board of Directors. Holdings has designated Mark Kessel and Alastair J.J. Wood, M.D., both Managing Directors of Symphony Capital LLC, as the Holdings representatives, who were appointed to the Board on October 22, 2008.
2009-04-07 Mark Kessel Age: 67 Director Since: 2008 Mr. Kessel, a Managing Director of Symphony Capital LLC, has worked with Symphony since its inception. Board of Directors: Holdings has designated Mark Kessel and Alastair J.J. Wood, M.D., both Managing Directors of Symphony Capital LLC, as the Holdings representatives, who were appointed to the Board on October 22, 2008. Director Compensation: Messrs. Kessel and Kollins and Dr. Wood do not receive fees from the Company in connection with their service as members of the Board of Directors.
2010-05-28 MARK KESSEL Age: 68 Director Since: 2008 ... Mr. Kessel is a Managing Director of Symphony Capital LLC ... Director Compensation table shows Mark Kessel total compensation as $34,200.
2010-11-12 Mark Kessel(3) 27,207,118 25.5 %
2011-02-18 Mark Kessel(3)

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22